Market Overview

The global market for musculoskeletal disorders treatment was valued at USD 186.02 billion in 2023 and is projected to reach USD 326.26 billion by 2032, growing at a CAGR of 6.0% from 2024 to 2032. This market encompasses treatments for conditions affecting muscles, bones, tendons, ligaments, and nerves, such as arthritis, tendonitis, carpal tunnel syndrome, and back pain.

Download a sample of this report @https://www.towardshealthcare.com/personalized-scope/5148

Market Highlights

• Osteoarthritis led the market in 2023, holding a 33% share in the type segment.
• Medications accounted for over 60% of the market in 2023.
• North America was the largest regional market, holding a 37% market share in 2023.

Market Drivers and Trends

1. Rising Demand for Joint Replacement Implants: The demand for joint replacement surgeries and implants, such as knee and hip replacements, is increasing due to the aging population, greater awareness of treatment options, and advancements in medical technology. For example, Goa Medical College in India introduced the country’s first coated knee implants in March 2024, projected to cost under INR 1 lakh (approximately USD 1,200), with a lifespan of up to 30 years.
2. Patient Preference for Non-Invasive Treatments: There is a growing preference among patients for non-invasive and minimally invasive treatments, such as medications, physical therapy, and ergonomic adjustments, over traditional surgeries. This trend is driving innovation in less invasive medical technologies.
3. Impact of Sedentary Lifestyles: Sedentary lifestyles and rising obesity rates are contributing to the increased prevalence of musculoskeletal disorders like arthritis and osteoporosis. This has led to a greater demand for treatments that manage pain and improve mobility.
4. Government Initiatives and Support: Governments worldwide are promoting health and facilitating access to treatment through awareness campaigns, funding research, and creating regulations to ensure safe and effective treatments for musculoskeletal disorders. These initiatives are shaping the market by encouraging innovation and making treatments accessible to all.
5. Technological Advancements and Innovations: Technological advancements, including the development of new medications, improved surgical techniques, and innovative medical devices, are driving market growth. Notable recent approvals include the FDA’s approval of Abrocitinib (Cibinqo) for rheumatoid arthritis in January 2024, and Jubbonti (denosumab-bbz), a RANKL inhibitor biosimilar, in March 2024.

Competitive Landscape

The musculoskeletal disorders treatment market is highly competitive, with major players such as Johnson & Johnson, Pfizer, Novartis, Abbott Laboratories, Medtronic, Stryker Corporation, Hoffmann-La Roche Ltd., Amgen Inc., Arthrex, Inc., Enovis, Globus Medical, and NuVasive actively competing. These companies focus on developing new medications, medical devices, and rehabilitation tools, driven by research and development initiatives.

Recent Developments

March 2024: FDA approved Tyenne (tocilizumab-aazq), a biosimilar of Actemra, for treating multiple arthritis types.
September 2020: Lupin launched a generic version of leflunomide for treating active rheumatoid arthritis in the U.S., enhancing treatment access for patients.

Key Market Segments

By Type:

• Tendonitis
• Osteoarthritis
• Rheumatoid Arthritis
• Carpal Tunnel Syndrome
• Fibromyalgia
• Other Musculoskeletal Disorders

By Product Type:

• Medications:
  • Pain Relievers
  • Anti-inflammatory Drugs
  • Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
  • Other Medications
• Implants:
  • Joint Replacement Implants (Hip, Knee, Shoulder, Elbow)
  • Spinal Implants
  • Fracture Repair Implants
• Prosthetics and Orthotics:
  • Prosthetic Devices
  • Braces
• Physical Therapy Equipment

By End User:

• • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Home Care Settings

By Geography:

• • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • South America

Read Also: https://www.healthcarewebwire.com/biological-safety-testing-products-and-services-market-size/

Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/musculoskeletal-disorders-treatment-market-sizing

To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5148

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare